Other Species / Isoforms
  LIMK1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S58-p
RCCDCSAsLSHQYYE
0 1
LIMK1 (human) RCCDCSAsLSHQYYE S58-p
LIMK1 (mouse) RCCECSVSLSHQYYE S58
LIMK1 (rat) RCCECSTSLSHQYYE S58
S181-p
GKRGLSVsIDPPHGP
0 1
LIMK1 (human) GKRGLSVsIDPPHGP S181-p
LIMK1 (mouse) GKRGLSVSIDPPHGP S181
LIMK1 (rat) GKRGLSVSIDPPHGP S181
S210-p
GVDPGCMsPDVkNSI
Upstream
0 13
Treatment
  • nocodazole
  • thymidine
LIMK1 (human) GVDPGCMsPDVkNSI S210-p
LIMK1 (mouse) GVDPGCMsPDVKNSI S210-p
LIMK1 (rat) GVDPGCMSPDVKNSI S210
K214-ub
GCMsPDVkNSIHVGD
0 2
LIMK1 (human) GCMsPDVkNSIHVGD K214-ub
LIMK1 (mouse) GCMsPDVKNSIHVGD K214
LIMK1 (rat) GCMSPDVKNSIHIGD K214
T229-p
RILEINGtPIRNVPL
0 6
LIMK1 (human) RILEINGtPIRNVPL T229-p
LIMK1 (mouse) RILEINGTPIRNVPL T229
LIMK1 (rat) RILEINGTPIRNVPL T229
T253-p
TSRLLQLtLEHDPHD
Upstream
0 1
Treatment
  • nocodazole
  • thymidine
LIMK1 (human) TSRLLQLtLEHDPHD T253-p
LIMK1 (mouse) TSRLLQLTLEHDPHD T253
LIMK1 (rat) TSRLLQLTLEHDPHD T253
T270-p
GHGLGPEtSPLsSPA
0 1
LIMK1 (human) GHGLGPEtSPLsSPA T270-p
LIMK1 (mouse) GHGPVSDPsPLSsPV P270
LIMK1 (rat) GHGPVSDPSPLASPV P270
S271
HGLGPEtSPLsSPAY
0 2
LIMK1 (human) HGLGPEtSPLsSPAY S271
LIMK1 (mouse) HGPVSDPsPLSsPVH S271-p
LIMK1 (rat) HGPVSDPSPLASPVH S271
S274-p
GPEtSPLsSPAYTPS
Upstream
0 1
Treatment
  • nocodazole
  • thymidine
LIMK1 (human) GPEtSPLsSPAYTPS S274-p
LIMK1 (mouse) VSDPsPLSsPVHtPS S274
LIMK1 (rat) VSDPSPLASPVHTPS A274
S275
PEtSPLsSPAYTPSG
0 1
LIMK1 (human) PEtSPLsSPAYTPSG S275
LIMK1 (mouse) SDPsPLSsPVHtPSG S275-p
LIMK1 (rat) SDPSPLASPVHTPSG S275
T279
PLsSPAYTPSGEAGs
0 1
LIMK1 (human) PLsSPAYTPSGEAGs T279
LIMK1 (mouse) PLSsPVHtPSGQAAS T279-p
LIMK1 (rat) PLASPVHTPSGQAGS T279
S286-p
TPSGEAGssARQKPV
0 1
LIMK1 (human) TPSGEAGssARQKPV S286-p
LIMK1 (mouse) tPSGQAASSARQKPV S286
LIMK1 (rat) TPSGQAGSSARQKPV S286
S287-p
PSGEAGssARQKPVL
0 1
LIMK1 (human) PSGEAGssARQKPVL S287-p
LIMK1 (mouse) PSGQAASSARQKPVL S287
LIMK1 (rat) PSGQAGSSARQKPVL S287
S296-p
RQKPVLRsCsIDRsP
0 4
LIMK1 (human) RQKPVLRsCsIDRsP S296-p
LIMK1 (mouse) RQKPVLRsCsIDTsP S296-p
LIMK1 (rat) RQKPVLRSCSIDTSP S296
S298-p
KPVLRsCsIDRsPGA
0 20
LIMK1 (human) KPVLRsCsIDRsPGA S298-p
LIMK1 (mouse) KPVLRsCsIDTsPGT S298-p
LIMK1 (rat) KPVLRSCSIDTSPGA S298
S302-p
RsCsIDRsPGAGsLG
Upstream
0 8
Treatment
  • vemurafenib
LIMK1 (human) RsCsIDRsPGAGsLG S302-p
LIMK1 (mouse) RsCsIDTsPGTSSLA S302-p
LIMK1 (rat) RSCSIDTSPGAGSLV S302
S307-p
DRsPGAGsLGsPAsQ
Upstream
Downstream
1 4
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Kinase, in vitro:
  • AurA (human)
Putative in vivo kinases:
  • AurA (human)
LIMK1 (human) DRsPGAGsLGsPAsQ S307-p
LIMK1 (mouse) DTsPGTSSLAsPASQ S307
LIMK1 (rat) DTSPGAGSLVSPASQ S307
S310-p
PGAGsLGsPAsQRKD
Upstream
1 27
Kinase, in vitro:
  • P38A (human)
Treatment
  • ischemia
LIMK1 (human) PGAGsLGsPAsQRKD S310-p
LIMK1 (mouse) PGTSSLAsPASQRKD S310-p
LIMK1 (rat) PGAGSLVSPASQRKD S310
S313-p
GsLGsPAsQRKDLGr
0 2
LIMK1 (human) GsLGsPAsQRKDLGr S313-p
LIMK1 (mouse) SSLAsPASQRKDLGR S313
LIMK1 (rat) GSLVSPASQRKDLGR S313
R320-m1
sQRKDLGrSEsLRVV
0 1
LIMK1 (human) sQRKDLGrSEsLRVV R320-m1
LIMK1 (mouse) SQRKDLGRSEsLRVV R320
LIMK1 (rat) SQRKDLGRSESLRVV R320
S323-p
KDLGrSEsLRVVCRP
Upstream
Downstream
1 3
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • MAPKAPK2 (human)
Putative in vivo kinases:
  • MAPKAPK2 (human)
Regulatory protein:
  • VEGFR2 (human)
Treatment
  • VEGF
LIMK1 (human) KDLGrSEsLRVVCRP S323-p
LIMK1 (mouse) KDLGRSEsLRVVCRP S323-p
LIMK1 (rat) KDLGRSESLRVVCRP S323
S337-p
PHRIFRPsDLIHGEV
Upstream
0 4
Treatment
  • nocodazole
  • thymidine
LIMK1 (human) PHRIFRPsDLIHGEV S337-p
LIMK1 (mouse) PHRIFRPSDLIHGEV S337
LIMK1 (rat) PHRIFRPSDLIHGEV S337
P492
MVDEKTQPEGLRSLK
0 1
LIMK1 (human) MVDEKTQPEGLRSLK P492
LIMK1 (mouse) MIDEKNQsEDLRSLK S492-p
LIMK1 (rat) MIDEKGQSEDLRSLK S492
T508-p
PDRKKRYtVVGNPYW
Upstream
Downstream
30 3
LIMK1 (human)
T508-p
LIMK1 (mouse)
T508-p
LIMK1 (rat)
T508-p
Effects on Modified Protein
  • activity, induced
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cell motility, induced
Kinase, in vitro:
  • AurA (human)
  • PAK1 (human)
  • PAK4 (human)
  • PAK6 (human)
  • ROCK1 (human)
Putative in vivo kinases:
  • AurA (human)
  • PAK4 (human)
  • PAK6 (mouse)
  • ROCK1 (human)
Regulatory protein:
  • LIMK1 (human)
  • Merlin (mouse)
  • NISCH (mouse)
  • PAK1 (human)
  • PAK6 (human)
  • PRKD3 (human)
  • PTEN (human)
  • RAC1 (human)
  • YB-1 (human)
Treatment
  • BI-D1870
  • CTGF
  • estradiol
  • fibronectin
  • fluid_shear_stress
  • GNF2
  • Go_6976
  • H1152
  • heat_shock
  • imatinib
  • interleukin-6-hydroxymethyl-chiro-inositol-2(R)-2-methyl-3-O-octadecylcarbonate
  • LPA
  • LY294002
  • miRNA
  • PF-03758309
  • phorbol_ester
  • RGDS
  • Ro6842262
  • serum
  • siRNA
  • tanespimycin
  • thrombin
  • Y27632
LIMK1 (human) PDRKKRYtVVGNPYW T508-p
LIMK1 (mouse) PDRKKRYtVVGNPYW T508-p
LIMK1 (rat) PDRKKRYtVVGNPYW T508-p
S534-p
DEKVDVFsFGIVLCE
0 1
LIMK1 (human) DEKVDVFsFGIVLCE S534-p
LIMK1 (mouse) DEKVDVFSFGIVLCE S534
LIMK1 (rat) DEKVDVFSFGIVLCE S534
S637-p
ETYRRGEsGLPAHPE
0 1
LIMK1 (human) ETYRRGEsGLPAHPE S637-p
LIMK1 (mouse) ETYRRGESSLPAHPE S637
LIMK1 (rat) ETYRRGESSLPAHPE S637